Tony Atala: Artificial Bladder by Krishnendu Saha

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Artificial Bladder)
(Artificial Bladder)
Line 27: Line 27:
*1999: Artificial bladders consist of the patient's own cells were implanted into 7 volunteers between the ages of 4 and 19. All the patients were suffering from urinary incontinence.
*1999: Artificial bladders consist of the patient's own cells were implanted into 7 volunteers between the ages of 4 and 19. All the patients were suffering from urinary incontinence.
*2003: The patent for the process was licensed to Tengion Inc. A company dedicated to providing solutions through regenerative medicine. Dr. Atala is said to be the scientific founder of Tengion.
*2003: The patent for the process was licensed to Tengion Inc. A company dedicated to providing solutions through regenerative medicine. Dr. Atala is said to be the scientific founder of Tengion.
-
*2006: The Lancet, a British medical journal, reports on the first time artificial organs have been successfully implanted in humans. This was 7 years after the original implantation back in 1999 and the report stated the volunteers were healthy and leading normal lives.
+
*2006: British medical journal ''The Lancet'' reported for the first time artificial organs have been successfully implanted in humans. This was 7 years after the original implantation back in 1999 and the report stated the volunteers were healthy and leading normal lives.
*2009: Phase II clinical trials initiated and completed by Tengion for the artificial bladder (Neo-bladder Augment)
*2009: Phase II clinical trials initiated and completed by Tengion for the artificial bladder (Neo-bladder Augment)

Revision as of 18:42, 9 April 2013

Anthony Atala, M.D. is the Director of the Wake Forest Institute for Regenerative Medicine and Professor and Chair of the Department of Urology at Wake Forest School of Medicine and one of the leading scientists in the fields of tissue engineering and regenerative medicine.

Dr Anthony Atala © Children's Hospital Boston
Dr Anthony Atala © Children's Hospital Boston

Contents

Short Biography

Dr. Atala graduated from University of Miami with Psychology major and completed a medical degree in urology from University of Louisville. He pursued a fellowship at Children's Hospital Boston, Massachusetts (affiliated with Harvard Medical School) and started his independent career at the same institute developing artificial organs for humans. In 1999, his team reported the successful creation and transplantation of artificial urinary bladder in beagle dogs that showed excellent functional capabilities in terms of retaining urine and normal elastic properties. After serving as the Director of the Laboratory for Tissue Engineering and Cellular Therapeutics at Children's Hospital Boston, Dr. Atala later moved to Wake Forest Baptist Medical Center in North Carolina and continued his seminal work of lab-grown organs. In 2006, his team reported succesful transplantation of engineered bladder in humans without any major complications. The patients were monitored for 5 years after surgery to determine long-term efects. As of 2013, he is the W. H. Boyce Professor and Director of the Wake Forest Institute of Regenerative Medicine.

Major Accomplishments

  • Developed and successfully transplanted lab-grown artificial urinary bladder using patients urothelial cells.
  • Harvested amniotic fluid stem cells (AFS cells) from pregnant women, avoiding the ethical issues regarding the embryonic stem cells (ESCs).These cells are easier to culture and unlike ESCs they do not form teratoma. AFS cells are also pluripotent, thereby can differentiate into various tissue types and have tremendous potential for future regenerative medicine.

Awards and Honors

Dr. Atala have received numerous prestigious awards including-

  • Christopher Columbus Foundation Award
  • The World Technology Award in Health and Medicine
  • Samuel D. Gross Prize
  • Barringer Medal
  • Gold Cytoscope award

In 2007, his work on artificial bladder was listed as Time Magazine's top 10 medical breakthroughs and No. 1 Top Science story by Discover Magazine. In 2009, U.S. News and World Reports featured Dr. Atala as one of the 14 pioneers of medical progess in the 21st century. Dr. Atala serves as editor and associate editor in many peer-reviewed journals including Stem Cells-Translational Medicine, Current Stem Cell Research, and Tissue Engineering and Regenerative Medicine. He is also editors of numerous books in the area of regenerative medicine and urology. He published more than 300 journal articles and applied for or received over 200 national and international patents. He were also invited to give TED lecture on artificially-grown organs.

Artificial Bladder

Importance and

Brief Timeline

  • 19:
  • 1996: Bladder shaped mold was created and was seeded with urothelial cells on the inside and muscle cells on the outside.
  • 1998: Lab-grown bladder successfully transplanted into dogs. After one year, article published in Nature Biotechnology reporting that the bladder was fully functional for 11 months.
  • 1999: Artificial bladders consist of the patient's own cells were implanted into 7 volunteers between the ages of 4 and 19. All the patients were suffering from urinary incontinence.
  • 2003: The patent for the process was licensed to Tengion Inc. A company dedicated to providing solutions through regenerative medicine. Dr. Atala is said to be the scientific founder of Tengion.
  • 2006: British medical journal The Lancet reported for the first time artificial organs have been successfully implanted in humans. This was 7 years after the original implantation back in 1999 and the report stated the volunteers were healthy and leading normal lives.
  • 2009: Phase II clinical trials initiated and completed by Tengion for the artificial bladder (Neo-bladder Augment)
Personal tools